Physician Assistant Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Kaitlyn Graham

Psychiatry Saint Marys, WV Physician Assistant

NPI 1972268530 CMS profile 11257873

210 2Nd St, Saint Marys, WV 26170

Open in the dashboard

General payments

$2,677

117 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Kaitlyn Graham of Saint Marys, WV is reported in the CMS Open Payments database as having received $2,677 across 117 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $419 20
2023 General $1,509 67
2022 General $733 29
2021 General $16 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kaitlyn Graham
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Kaitlyn Graham were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Kaitlyn Graham Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $16 $143 $43–$576 $132
2022 $733 $153 $50–$590 $149
2023 $1,509 $170 $56–$651 $160
2024 $419 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. AbbVie, Inc. $565 25 payments
  2. Alkermes, Inc. $403 24 payments
  3. Teva Pharmaceuticals USA, Inc. $363 21 payments
  4. Corium, Inc. $302 9 payments
  5. Axsome Therapeutics, Inc. $257 10 payments
  6. ITI, Inc. $221 4 payments
  7. Otsuka America Pharmaceutical, Inc. $188 5 payments
  8. Vanda Pharmaceuticals Inc. $140 6 payments
  9. Jazz Pharmaceuticals Inc. $71 3 payments
  10. Lundbeck LLC $66 4 payments
  11. Other $102 6 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $2,630 116 payments
  2. Education $47 1 payment
Products named General payments · program years 2021–2024
  1. VRAYLAR $565 25 payments
  2. LYBALVI $331 21 payments
  3. Azstarys $302 9 payments
  4. ARISTADA Cns $284 19 payments
  5. ARISTADA Cns $284 19 payments
  6. Auvelity $231 9 payments
  7. ARISTADA Cns $230 16 payments
  8. ARISTADA Cns $230 16 payments
  9. CAPLYTA $221 4 payments
  10. AUSTEDO $189 11 payments
  11. Other $1,226 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

364

Median for Physician Assistant: 241

Drug cost

$39,323

Median for Physician Assistant: $4,110

Branded share of claims

11.3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Caplyta Lumateperone Tosylate Brand 21 $35,207
Vilazodone Hcl Generic 12 $882
Prazosin Hcl Generic 32 $395
Fluoxetine Hcl Generic 19 $305
Mirtazapine Generic 17 $297
Clonazepam Generic 38 $297
Bupropion Xl Bupropion Hcl Brand 20 $267
Quetiapine Fumarate Generic 33 $263
Propranolol Hcl Generic 16 $251
Lamotrigine Generic 21 $246

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$5,645

Medicare's payments for the services billed

Medicare patients

24

Average age 56

Services billed

82

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 75%
High blood pressure 54%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VRAYLAR
  • AbbVie, Inc. $150
$150 — —
Austedo XR
  • Teva Pharmaceuticals USA, Inc. $121
$121 — —
XYWAV
  • JAZZ PHARMACEUTICALS INC. $34
$34 — —
ARISTADA
  • Alkermes, Inc. $26
$26 — —
Sunosi
  • Axsome Therapeutics, Inc. $25
$25 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record